Suppr超能文献

颗粒蛋白前体突变与临床和神经病理学阿尔茨海默病。

Progranulin mutations in clinical and neuropathological Alzheimer's disease.

机构信息

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

出版信息

Alzheimers Dement. 2022 Dec;18(12):2458-2467. doi: 10.1002/alz.12567. Epub 2022 Feb 9.

Abstract

INTRODUCTION

Progranulin (GRN) mutations occur in frontotemporal lobar degeneration (FTLD) and in Alzheimer's disease (AD), often with TDP-43 pathology.

METHODS

We determined the frequency of rs5848 and rare, pathogenic GRN mutations in two autopsy and one family cohort. We compared Braak stage, β-amyloid load, hyperphosphorylated tau (PHFtau) tangle density and TDP-43 pathology in GRN carriers and non-carriers.

RESULTS

Pathogenic GRN mutations were more frequent in all cohorts compared to the Genome Aggregation Database (gnomAD), but there was no evidence for association with AD. Pathogenic GRN carriers had significantly higher PHFtau tangle density adjusting for age, sex and APOE ε4 genotype. AD patients with rs5848 had higher frequencies of hippocampal sclerosis and TDP-43 deposits. Twenty-two rare, pathogenic GRN variants were observed in the family cohort.

DISCUSSION

GRN mutations in clinical and neuropathological AD increase the burden of tau-related brain pathology but show no specific association with β-amyloid load or AD.

摘要

简介

颗粒体蛋白前体(GRN)突变可发生于额颞叶痴呆(FTLD)和阿尔茨海默病(AD)中,通常伴有 TDP-43 病理学改变。

方法

我们在两个尸检队列和一个家系队列中,测定了 rs5848 及罕见致病性 GRN 突变的频率。我们比较了 GRN 携带者与非携带者的 Braak 分期、β-淀粉样蛋白负荷、磷酸化 tau(PHFtau)缠结密度和 TDP-43 病理学。

结果

与基因组聚集数据库(gnomAD)相比,所有队列中的致病性 GRN 突变频率均较高,但与 AD 无关。在调整年龄、性别和 APOE ε4 基因型后,致病性 GRN 携带者的 PHFtau 缠结密度显著升高。rs5848 的 AD 患者的海马硬化和 TDP-43 沉积物的频率更高。在家系队列中观察到 22 种罕见的致病性 GRN 变体。

讨论

临床和神经病理学 AD 中的 GRN 突变增加了与 tau 相关的脑病理学负担,但与 β-淀粉样蛋白负荷或 AD 无特定关联。

相似文献

1
Progranulin mutations in clinical and neuropathological Alzheimer's disease.
Alzheimers Dement. 2022 Dec;18(12):2458-2467. doi: 10.1002/alz.12567. Epub 2022 Feb 9.
2
Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
Acta Neuropathol. 2013 Feb;125(2):289-302. doi: 10.1007/s00401-012-1048-7. Epub 2012 Sep 28.
5
Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
Acta Neuropathol. 2010 Jan;119(1):111-22. doi: 10.1007/s00401-009-0576-2. Epub 2009 Aug 2.
9
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
Arch Neurol. 2011 Apr;68(4):488-97. doi: 10.1001/archneurol.2011.53.

引用本文的文献

1
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases.
Commun Biol. 2025 Jun 2;8(1):844. doi: 10.1038/s42003-025-08272-9.
2
LATE-NC Stage 3: a diagnostic rubric to differentiate severe LATE-NC from FTLD-TDP.
Acta Neuropathol. 2025 Apr 28;149(1):38. doi: 10.1007/s00401-025-02876-5.
4
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease.
Alzheimers Dement (N Y). 2024 Nov 22;10(4):e70014. doi: 10.1002/trc2.70014. eCollection 2024 Oct-Dec.
5
7
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.
Cytokine Growth Factor Rev. 2024 Apr;76:142-159. doi: 10.1016/j.cytogfr.2023.11.001. Epub 2023 Nov 11.
8
A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.
Mol Neurodegener. 2023 Jun 22;18(1):40. doi: 10.1186/s13024-023-00633-4.
10
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Int J Mol Sci. 2022 Dec 12;23(24):15755. doi: 10.3390/ijms232415755.

本文引用的文献

1
The mutational constraint spectrum quantified from variation in 141,456 humans.
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
2
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.
Neurobiol Aging. 2020 Apr;88:61-70. doi: 10.1016/j.neurobiolaging.2019.12.012. Epub 2019 Dec 20.
3
Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms.
Sci Rep. 2019 Dec 13;9(1):19123. doi: 10.1038/s41598-019-55636-3.
5
Genetic screen in a large series of patients with primary progressive aphasia.
Alzheimers Dement. 2019 Apr;15(4):553-560. doi: 10.1016/j.jalz.2018.10.009. Epub 2019 Jan 25.
6
Translating the biology of aging into novel therapeutics for Alzheimer disease.
Neurology. 2019 Jan 8;92(2):84-93. doi: 10.1212/WNL.0000000000006745. Epub 2018 Dec 7.
7
Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
Curr Med Chem. 2019;26(30):5684-5710. doi: 10.2174/0929867326666181203124102.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验